Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 30/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

38%

3 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

3(42.9%)

Phase 4

3(42.9%)

Phase 1

1(14.3%)

7Total

N/A(3)

Phase 4(3)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT03647930Not ApplicableCompleted

The Effect of Arista on Post-Operative Bleeding and Wound Drainage Following Mastectomy

Role: lead

NCT03199560Phase 4Unknown

Tilmanocept vs Sulfur Colloid in Sentinel Lymph Node Biopsy

Role: lead

NCT03027115Phase 4Unknown

Hernia Surgery Urinary Retention

Role: lead

NCT03268395Not ApplicableUnknown

Correlation of CO2 Measured by Blood Gas vs Transcutaneous Monitor

Role: lead

NCT01139996Phase 4Terminated

Use of Transdermal Clonidine in Trauma Patients

Role: lead

NCT02623036Phase 1Unknown

The Use of Ambulatory Blood Pressure Monitors to Assess Angiotensin Converting Enzyme Inhibitors

Role: lead

NCT00685477Not ApplicableCompleted

Dose Response of Intravenous Sincalide(CCK-8) for Gallbladder Emptying

Role: collaborator

NCT00597987Completed

BRCA1 Haploinsufficiency and Gene Expression

Role: collaborator

All 8 trials loaded